Vapotherm (NYSE:VAPO – Get Rating) and Cochlear (OTCMKTS:CHEOF – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk. Valuation & Earnings This table compares Vapotherm and Cochlear’s revenue, earnings per […]
Shares of Vapotherm, Inc. (NYSE:VAPO – Get Rating) fell 12.2% during trading on Wednesday . The stock traded as low as $0.50 and last traded at $0.50. 140,923 shares changed hands during mid-day trading, a decline of 41% from the average session volume of 240,100 shares. The stock had previously closed at $0.57. Vapotherm Stock […]
Vapotherm, Inc. (NYSE:VAPO – Get Rating) – William Blair reduced their Q2 2023 EPS estimates for Vapotherm in a research report issued to clients and investors on Wednesday, May 10th. William Blair analyst M. Kaczor now anticipates that the company will earn ($0.45) per share for the quarter, down from their previous estimate of ($0.32). […]
Vapotherm (NYSE:VAPO – Get Rating) will post its quarterly earnings results after the market closes on Wednesday, May 3rd. Analysts expect Vapotherm to post earnings of ($0.41) per share for the quarter. Vapotherm has set its FY 2023 guidance at EPS.Individual that wish to register for the company’s earnings conference call can do so using […]
Vapotherm, Inc. (NYSE:VAPO – Get Rating) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 1,820,000 shares, a growth of 16.7% from the March 31st total of 1,560,000 shares. Based on an average daily trading volume, of 214,600 shares, the days-to-cover ratio is […]